Teprotumumab 500mg powder for solution for infusion vials
- SNOMED code
45531711000001102- Active compound
- Teprotumumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Teprotumumab
— 500 mg
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Tepezza 500mg powder for concentrate for solution for infusion vials (Amgen Ltd)
in short Tepezza 500mg pdr for concentrate for inf vials
Tepezza 500mg powder for concentrate for solution for infusion vials
- SNOMED code
45529111000001101- Supplier
- Amgen Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Tepezza 500mg powder for concentrate for solution for infusion vials (Amgen Ltd) 1 vial45529211000001107 ref. pack | 💯 Available Legal category: POM | 8715131030667End: 08715131030667 | NHS Indicative Price £12,974 | • Hospital |
| — |
Reference packs
Teprotumumab 500mg powder for solution for infusion vials 1 vial
- SNOMED code
45528911000001106- Quantity and unit
- 1 vial
- Packs